Pierre-Aurélien Beuriat, Anthime Flaus, Aurélie Portefaix, Alexandru Szathmari, Marc Janier, Marc Hermier, Sylvie Lorthois-Ninou, Christian Scheiber, Sibel Isal, Nicolas Costes, Ines Merida, Sophie Lancelot, Alexandre Vasiljevic, Pierre Leblond, Cécile Faure Conter, Clarisse Saunier, Behrouz Kassai, Matthieu Vinchon, Federico Di Rocco, Carmine Mottolese
PURPOSE: MRI is the main imaging modality for pediatric brain tumors, but amino acid PET can provide additional information. Simultaneous PET-MRI acquisition allows to fully assess the tumor and lower the radiation exposure. Although symptomatic posterior fossa tumors are typically resected, the patient management is evolving and will benefit from an improved preoperative tumor characterization. We aimed to explore, in children with newly diagnosed posterior fossa tumor, the complementarity of the information provided by amino acid PET and MRI parameters and the correlation to histopathological results...
March 25, 2024: Clinical Nuclear Medicine